Yubo International Biotech Limited (YBGJ)

Market Cap	2.32M
Revenue (ttm)	-18.00
Net Income (ttm)	-1.41M
Shares Out	170.42M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,460
Average Volume	1,973
Open	0.0130
Previous Close	0.0136
Day's Range	0.0130 - 0.0149
52-Week Range	0.0079 - 0.2900
Beta	0.62
RSI	38.76
Earnings Date	Nov 13, 2025

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2024, YBGJ's revenue was $3,470, a decrease of -99.43% compared to the previous year's $604,676. Losses were -$1.78 million, 48.6% more than in 2023.